JP2012533519A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533519A5
JP2012533519A5 JP2012515517A JP2012515517A JP2012533519A5 JP 2012533519 A5 JP2012533519 A5 JP 2012533519A5 JP 2012515517 A JP2012515517 A JP 2012515517A JP 2012515517 A JP2012515517 A JP 2012515517A JP 2012533519 A5 JP2012533519 A5 JP 2012533519A5
Authority
JP
Japan
Prior art keywords
cell preparation
patient
cell
hematopoietic stem
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012515517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533519A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/058675 external-priority patent/WO2010146177A1/en
Publication of JP2012533519A publication Critical patent/JP2012533519A/ja
Publication of JP2012533519A5 publication Critical patent/JP2012533519A5/ja
Pending legal-status Critical Current

Links

JP2012515517A 2009-06-18 2010-06-18 骨髄細胞外マトリックス抽出物およびその治療上の使用 Pending JP2012533519A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21818209P 2009-06-18 2009-06-18
US61/218,182 2009-06-18
PCT/EP2010/058675 WO2010146177A1 (en) 2009-06-18 2010-06-18 Bone marrow extracellular matrix extract and therapeutic use thereof

Publications (2)

Publication Number Publication Date
JP2012533519A JP2012533519A (ja) 2012-12-27
JP2012533519A5 true JP2012533519A5 (enExample) 2013-05-30

Family

ID=42556414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012515517A Pending JP2012533519A (ja) 2009-06-18 2010-06-18 骨髄細胞外マトリックス抽出物およびその治療上の使用

Country Status (5)

Country Link
US (1) US20120065620A1 (enExample)
EP (1) EP2442837B1 (enExample)
JP (1) JP2012533519A (enExample)
CN (1) CN102802686A (enExample)
WO (1) WO2010146177A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105395570A (zh) * 2015-09-23 2016-03-16 广东颐养抗衰老研究院 一种用于治疗老年性白血病的组合物
US12472282B2 (en) 2018-03-30 2025-11-18 University Of Rochester Bioengineered wharton's jelly derived extracellular matrix

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674750A (en) 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
IT1282207B1 (it) * 1995-11-20 1998-03-16 Fidia Advanced Biopolymers Srl Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
WO2000046349A1 (en) * 1999-02-04 2000-08-10 Technion Research & Development Foundation Ltd. Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
WO2003038048A2 (en) * 2001-10-30 2003-05-08 The United States Of America As Represented By The Secretary Of The Navy Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
AU2004242091C1 (en) * 2003-05-07 2009-12-24 La Jolla Institute For Molecular Medicine Administration of hyaluronic acid to enhance the function of transplanted stem cells
US7326571B2 (en) * 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
JP2005192521A (ja) * 2004-01-09 2005-07-21 Hiroko Sato 部分分解重合性タンパク質からなる造血幹細胞を含む未熟な血液細胞（ｈｓｃ）の増殖促進用支持体およびその支持体を使用したｈｓｃの製造方法。
ES2538305T3 (es) * 2004-10-25 2015-06-18 Cellerant Therapeutics, Inc. Métodos para expandir poblaciones de células mieloides y usos de las mismas
EP1965812A4 (en) * 2005-11-08 2010-02-24 Georgia Tech Res Inst AZELLULARIZED BIOLOGICAL MATERIAL FROM EMBRYONAL STEM CELLS
JP5341525B2 (ja) * 2006-02-14 2013-11-13 セルラント セラピューティクス，インコーポレイティド 造血幹細胞の生着を増強するための方法および組成物
CN101062428A (zh) * 2006-04-24 2007-10-31 中国人民解放军军事医学科学院野战输血研究所 一种组织工程化皮肤的构建方法与应用
EP2049129B1 (en) * 2006-06-22 2013-06-12 Yeda Research And Development Co., Ltd. Catecholamine receptor modulation
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
WO2009072990A1 (en) * 2007-12-06 2009-06-11 Agency For Science, Technology And Research Method for extracellular matrix mediated differentiation and proliferation of stem cells
WO2009080794A1 (en) * 2007-12-21 2009-07-02 Mc2 Cell Aps Method for preparing cell-specific extracellular matrices

Similar Documents

Publication Publication Date Title
Dabrowska et al. Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases
EP2422797A3 (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
WO2011150055A3 (en) Methods, substrates, and systems useful for cell seeding of medical grafts
HUP0400371A2 (hu) Szén-monoxid alkalmazása szerv átültetés utáni túlélésének vagy működésének javítására alkalmas gyógyszerkészítmény előállítására
CR20230147A (es) Preparación y almacenamiento de formulaciones de rna liposomal adecuadas para terapia
NZ603913A (en) Method of engrafting cells from solid tissues
SI1718338T1 (sl) Sestavki in metode za ciljno usmerjeno in vitro in in vivo dostavo zdravila v celice sesalcev preko bakterijsko pridobljenih intaktnih minicelic
WO2014186469A3 (en) Human application of engineered chimeric antigen receptor (car) t-cells
BR112013010853A2 (pt) "agentes citotóxicos compreendendo derivados de ansamitocina, composição farmacêutica e uso destes"
WO2012006100A3 (en) Methods and compositions for enhancing stem cell mobilization
WO2010082787A2 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
RU2009107030A (ru) Комбинированная терапия
WO2012071527A3 (en) Protein delivery from stem cell microcarriers
WO2011098762A8 (en) Antibodies
Liu et al. Permanently hypoxic cell culture yields rat bone marrow mesenchymal cells with higher therapeutic potential in the treatment of chronic myocardial infarction
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
WO2010108058A3 (en) Small molecule inhibitors of dusp6 and uses therefor
CA2526244A1 (en) Pharmaceutical combination of g-csf and plgf useful for blood stem cell mobilization
Zhong et al. Adhesion-assisted antioxidant-engineered mesenchymal stromal cells for enhanced cardiac repair in myocardial infarction
WO2010073126A3 (en) Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
BR112015010256A2 (pt) meio para cultivar, preservar e administrar células regenerativas
WO2011037416A3 (ko) 세포이식술을 위한 혼합세포복합체인 세포스페로이드의 제조방법 및 이의 이용방법
WO2007139939A3 (en) Methods and compositions using immunomodulatory compounds in combination therapy
RU2007132041A (ru) Биотрансплантат, способ его получения, способ лечения хронических диффузных заболеваний печени и способ лечения цироза печени и портальной гипертензии
WO2002053700A3 (en) Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof